Dyadic reports 35% revenue jump, 81% earnings gain for Q2

August 5, 2011 |

In Florida, enzyme maker Dyadic International reported a 35% gain in revenues and an 81% gain in earnings for Q2 2011, compared to Q2 2010. Among company highlights for the quarter, an R&D collaboration with Sanofi Pasteur and EnGen Bio,  an R&D and licensing deal with an undisclosed animal feed “major player”, and three new U.S. patents.

Category: Fuels

Thank you for visting the Digest.